| Similar Articles |
|---|
 |
Pharmaceutical Executive
October 1, 2011
Jennifer Ringler |
The "Mother" of Invention Abbey Meyers, Founder, National Organization of Rare Disorders, believes patient empowerment can foster change.   |
The Motley Fool
September 14, 2009
Brian Orelli |
The Clock Is Ticking for Elan Elan is getting closer to the Sept. 26 deadline to fix its contract with Johnson & Johnson. If it doesn't, Biogen Idec has the right to take full control of Elan's and Biogen's multiple-sclerosis drug, Tysabri. |
The Motley Fool
August 7, 2009
Brian Orelli |
A Billion-Dollar Lovers' Quarrel It looks like the triangle between partners Elan and Biogen Idec and third-wheel Johnson & Johnson over the multiple sclerosis drug Tysabri is going to get settled in court. |
Car and Driver
June 2006
Larry Webster |
The Father of the Dune Buggy Rides Again Despite tax bites, copycats, and bad deals, Bruce Meyers still just wants to have fun. |
Chemistry World
January 7, 2015
Rebecca Trager |
Revlon's former chief scientist claims he was fired over safety whistleblowing The former chief scientific officer of Revlon is suing the US cosmetics company, alleging that he was fired after raising safety concerns that its chief executive Lorenzo Delpani didn't want to hear. |
CIO
May 30, 2014
Ford Myers |
3 Quick Tips for Improving Your Professional Network Executive career coach Ford Meyers gives practical advice for making valuable connections both inside and outside your company. |
The Motley Fool
December 4, 2009
Brian Orelli |
Our Final Offer (Maybe)! That's a FACT! Biogen ups its bid for Facet. |
